In a previous study, it was observed that 5FU treatment promoted stemness of CRC by activating Wnt/β-catenin signaling in a p53-dependent manner [25], hence highlighting that targeting the Wnt/β-catenin signaling pathway can facilitate the inhibition of the CSC phenotype in various cancers, including CRC. This evidence concerns the gene TP53 and colorectal carcinoma.